U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 500

1.
ZEB1-repressed microRNAs inhibit autocrine signaling that promotes vascular mimicry of breast cancer cells
E M Langer, N D Kendsersky, C J Daniel, G M Kuziel, C Pelz, K M Murphy, M R Capecchi, R C Sears
Oncogene. 2018 Feb 22; 37(8): 1005–1019. Published online 2017 Oct 30. doi: 10.1038/onc.2017.356
PMCID:
PMC5823716
AbstractArticlePDF–3.8M
2.
Association of ARMS2 genotype with response to anti-vascular endothelial growth factor treatment in polypoidal choroidal vasculopathy
Un Chul Park, Joo Young Shin, Hum Chung, Hyeong Gon Yu
BMC Ophthalmol. 2017; 17: 241. Published online 2017 Dec 7. doi: 10.1186/s12886-017-0631-z
PMCID:
PMC5719580
AbstractArticlePDF–532K
3.
New roles for nuclear EGFR in regulating the stability and translation of mRNAs associated with VEGF signaling
Klaus Dittmann, Claus Mayer, Stefan Czemmel, Stephan M. Huber, H. Peter Rodemann
PLoS One. 2017; 12(12): e0189087. Published online 2017 Dec 18. doi: 10.1371/journal.pone.0189087
PMCID:
PMC5734708
AbstractArticlePDF–4.2M
4.
Endometrial Cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model
Sebastien Taurin, Chieh-Hsiang Yang, Maria Reyes, Sungpil Cho, Demetrius M. Coombs, Elke A. Jarboe, Theresa L. Werner, C. Matthew Peterson, Margit M. Janát-Amsbury
Int J Gynecol Cancer. 2018 Jan; 28(1): 152–160. Published online 2017 Sep 26. doi: 10.1097/IGC.0000000000001129
PMCID:
PMC5735020
AbstractArticlePDF–570K
5.
Ultrasound Molecular Imaging of VEGFR-2 in Clear-Cell Renal Cell Carcinoma Tracks Disease Response to Antiangiogenic and Notch-Inhibition Therapy
Juan D. Rojas, Fanglue Lin, Yun-Chen Chiang, Anna Chytil, Diana C. Chong, Victoria L. Bautch, W. Kimryn Rathmell, Paul A. Dayton
Theranostics. 2018; 8(1): 141–155. Published online 2018 Jan 1. doi: 10.7150/thno.19658
PMCID:
PMC5743465
AbstractArticlePDF–1.8M
6.
Phase Ib/II study of the safety and efficacy of combination therapy with multikinase vascular endothelial growth factor inhibitor Pazopanib and MEK inhibitor Trametinib in advanced soft tissue sarcoma
Vivek Subbiah, Christian Meyer, Ralph Zinner, Funda Meric-Bernstam, Marianna Zahurak, Ashley O’Connor, Jason Roszik, Kenna Shaw, Joseph Ludwig, Razelle Kurzrock, Nilofer Azad
Clin Cancer Res. Author manuscript; available in PMC 2018 Feb 1.
Published in final edited form as: Clin Cancer Res. 2017 Aug 1; 23(15): 4027–4034. Published online 2017 Apr 4. doi: 10.1158/1078-0432.CCR-17-0272
Correction in:
Clin Cancer Res. 2018 Jan 15; 24(2): 500–501.
PMCID:
PMC5754188
AbstractArticlePDF–789K
7.
Protective, repairing and fibrinolytic effects of rivaroxaban on vascular endothelium
Ezequiel Álvarez, Beatriz Paradela‐Dobarro, Sergio Raposeiras‐Roubín, José Ramón González‐Juanatey
Br J Clin Pharmacol. 2018 Feb; 84(2): 280–291. Published online 2017 Oct 25. doi: 10.1111/bcp.13440
PMCID:
PMC5777430
AbstractArticlePDF–560K
8.
VEGFR3 inhibition chemosensitizes lung adenocarcinoma A549 cells in the tumor-associated macrophage microenvironment through upregulation of p53 and PTEN
Ya Li, Yaguang Weng, Liang Zhong, Huimin Chong, Sicheng Chen, Yanting Sun, Wang Li, Qiong Shi
Oncol Rep. 2017 Nov; 38(5): 2761–2773. Published online 2017 Sep 19. doi: 10.3892/or.2017.5969
PMCID:
PMC5780029
AbstractArticlePDF–1.6M
9.
Bevacizumab-Induced Hypertension: Clinical Presentation and Molecular Understanding
Megan Li, Deanna L. Kroetz
Pharmacol Ther. Author manuscript; available in PMC 2019 Feb 1.
Published in final edited form as: Pharmacol Ther. 2018 Feb; 182: 152–160. Published online 2017 Sep 4. doi: 10.1016/j.pharmthera.2017.08.012
PMCID:
PMC5785435
AbstractArticlePDF–780K
10.
Inhibiting Histone Deacetylase as a Means to Reverse Resistance to Angiogenesis Inhibitors: Phase I Study of Abexinostat Plus Pazopanib in Advanced Solid Tumor Malignancies
Rahul Aggarwal, Scott Thomas, Nela Pawlowska, Imke Bartelink, Jennifer Grabowsky, Thierry Jahan, Amy Cripps, Armand Harb, Jim Leng, Anne Reinert, Ilaria Mastroserio, Thach-Giao Truong, Charles J. Ryan, Pamela N. Munster
J Clin Oncol. 2017 Apr 10; 35(11): 1231–1239. Published online 2017 Feb 21. doi: 10.1200/JCO.2016.70.5350
PMCID:
PMC5791833
AbstractArticlePDF–1.3M
11.
Fibrocytes: A Novel Stromal Cells to Regulate Resistance to Anti-Angiogenic Therapy and Cancer Progression
Hisatsugu Goto, Yasuhiko Nishioka
Int J Mol Sci. 2018 Jan; 19(1): 98. Published online 2017 Dec 29. doi: 10.3390/ijms19010098
PMCID:
PMC5796048
AbstractArticlePDF–516K
12.
“Vessels in the Storm”: Searching for Prognostic and Predictive Angiogenic Factors in Colorectal Cancer
Adriano Angelucci, Simona Delle Monache, Alessio Cortellini, Monica Di Padova, Corrado Ficorella
Int J Mol Sci. 2018 Jan; 19(1): 299. Published online 2018 Jan 19. doi: 10.3390/ijms19010299
PMCID:
PMC5796244
AbstractArticlePDF–1.4M
13.
New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications
Ye Wang, Liya Wang, Cheng Chen, Xiaoyuan Chu
Mol Cancer. 2018; 17: 22. Published online 2018 Feb 7. doi: 10.1186/s12943-018-0766-4
PMCID:
PMC5804051
AbstractArticlePDF–447K
14.
Characterization and validation of potential therapeutic targets based on the molecular signature of patient-derived xenografts in gastric cancer
Zuhua Chen, Wenwen Huang, Tiantian Tian, Wanchun Zang, Jingyuan Wang, Zhentao Liu, Zhongwu Li, Yumei Lai, Zhi Jiang, Jing Gao, Lin Shen
J Hematol Oncol. 2018; 11: 20. Published online 2018 Feb 13. doi: 10.1186/s13045-018-0563-y
PMCID:
PMC5809945
AbstractArticlePDF–8.3M
15.
Inhibition of Siah2 Ubiquitin Ligase by Vitamin K3 Attenuates Chronic Myeloid Leukemia Chemo-Resistance in Hypoxic Microenvironment
Jixian Huang, Ziyuan Lu, Yajuan Xiao, Bolin He, Chengyun Pan, Xuan Zhou, Na Xu, Xiaoli Liu
Med Sci Monit. 2018; 24: 727–735. Published online 2018 Feb 5. doi: 10.12659/MSM.908553
PMCID:
PMC5810368
AbstractArticlePDF–668K
16.
NRF2 regulates endothelial glycolysis and proliferation with miR-93 and mediates the effects of oxidized phospholipids on endothelial activation
Suvi M Kuosmanen, Emilia Kansanen, Minna U Kaikkonen, Virve Sihvola, Kati Pulkkinen, Henna-Kaisa Jyrkkänen, Pauli Tuoresmäki, Juha Hartikainen, Mikko Hippeläinen, Hannu Kokki, Pasi Tavi, Sami Heikkinen, Anna-Liisa Levonen
Nucleic Acids Res. 2018 Feb 16; 46(3): 1124–1138. Published online 2017 Nov 17. doi: 10.1093/nar/gkx1155
PMCID:
PMC5815049
AbstractArticlePDF–4.2M
17.
EZH2 modifies sunitinib resistance in renal cell carcinoma by kinome reprogramming
Remi Adelaiye-Ogala, Justin Budka, Nur P. Damayanti, Justine Arrington, Mary Ferris, Chuan-Chih Hsu, Sreenivasulu Chintala, Ashley Orillion, Kiersten Marie Miles, Li Shen, May Elbanna, Eric Ciamporcero, Sreevani Arisa, Piergiorgio Pettazzoni, Giulio F. Draetta, Mukund Seshadri, Bradley Hancock, Milan Radovich, Janaiah Kota, Michael Buck, Heike Keilhack, Brian P. McCarthy, Scott A. Persohn, Paul R. Territo, Yong Zang, Joseph Irudayaraj, W. Andy Tao, Peter Hollenhorst, Roberto Pili
Cancer Res. Author manuscript; available in PMC 2018 Dec 1.
Published in final edited form as: Cancer Res. 2017 Dec 1; 77(23): 6651–6666. Published online 2017 Oct 4. doi: 10.1158/0008-5472.CAN-17-0899
PMCID:
PMC5712262
AbstractArticlePDF–1.5M
18.
Non-small cell lung cancer is susceptible to induction of DNA damage responses and inhibition of angiogenesis by telomere overhang oligonucleotides
Neelu Puri, Ryan T. Pitman, Richard E. Mulnix, Terrianne Erickson, Audra N. Iness, Connie Vitali, Yutong Zhao, Ravi Salgia
Cancer Lett. Author manuscript; available in PMC 2018 Mar 6.
Published in final edited form as: Cancer Lett. 2014 Feb 1; 343(1): 14–23. Published online 2013 Sep 14. doi: 10.1016/j.canlet.2013.09.010
PMCID:
PMC5839143
AbstractArticlePDF–2.4M
19.
Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis
Richard M. Stone, Paul W. Manley, Richard A. Larson, Renaud Capdeville
Blood Adv. 2018 Feb 27; 2(4): 444–453. Published online 2018 Feb 27. doi: 10.1182/bloodadvances.2017011080
Correction in:
Blood Adv. 2018 Apr 10; 2(7): 787.
PMCID:
PMC5858474
AbstractArticlePDF–1.1M
20.
Selective IKK2 inhibitor IMD0354 disrupts NF-κB signaling to suppress corneal inflammation and angiogenesis
Anton Lennikov, Pierfrancesco Mirabelli, Anthony Mukwaya, Mira Schaupper, Muthukumar Thangavelu, Mieszko Lachota, Zaheer Ali, Lasse Jensen, Neil Lagali
Angiogenesis. 2018; 21(2): 267–285. Published online 2018 Jan 13. doi: 10.1007/s10456-018-9594-9
PMCID:
PMC5878206
AbstractArticlePDF–8.3M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center